Related Experiment Video
Updated: Aug 1, 2026

04:29
Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
Published on: January 7, 2019
Improving care for depression in patients with comorbid substance misuse
Katherine E Watkins1, Susan M Paddock, Lily Zhang
1RAND Corporation, Santa Monica, CA 90407-2138, USA.
The American Journal of Psychiatry
|January 5, 2006
Summary
Quality improvement programs effectively treat depression in patients with and without substance misuse. These programs reduce the likelihood of depressive disorders, showing benefits for both groups.
Area of Science:
- Clinical Psychology
- Psychiatry
- Public Health
Background:
- Co-occurring substance misuse is linked to poorer depression treatment outcomes.
- Depression management in substance misusers requires effective interventions.
Purpose of the Study:
- To evaluate the effectiveness of quality improvement programs for depression in substance misusers.
- To determine if comorbidity influences program effectiveness.
Main Methods:
- Group-level randomized controlled trial (Partners in Care).
- Comparison of two quality improvement programs (medication, therapy) against usual care.
- Logistic regression analysis of depression and treatment utilization rates.
Main Results:
- Quality improvement programs improved depression outcomes at 6-12 months for patients with and without substance misuse.
- Increased antidepressant use observed at 6 months in substance misusing group.
- Higher treatment utilization noted in non-substance misusing group.
Conclusions:
- Quality improvement programs are effective in reducing probable depressive disorders.
- Co-occurring substance misuse increases risk for poorer depression outcomes under usual care.
- No significant differential program-by-comorbidity effect found, except for psychotherapy use.
More Related Videos
Related Concept Videos
Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Substance Use Disorders Affecting Sleep
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Stress and Mental Health
Chronic stress profoundly affects mental health, significantly influencing mood, behavior, and overall quality of life. Research closely links chronic stress with mental health conditions such as depression, anxiety, and substance use disorders. Ongoing exposure to stress can lead to physiological and psychological changes, initiating a cycle of emotional distress and maladaptive coping mechanisms.
Individuals with depression often experience challenges in both their personal and professional...
Individuals with depression often experience challenges in both their personal and professional...
Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
Community Based Intervention
Community-based interventions in mental health represent a paradigm shift from institution-centered care to treatments embedded within the fabric of local communities. By prioritizing inclusion and leveraging existing societal structures, this approach fosters a supportive environment conducive to addressing mental health challenges while promoting individual dignity and agency.
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...

